Nsun2-mediated m5C methylation of Ncor1 exacerbates sepsis-induced cardiomyopathy by promoting mitochondrial

Chan Chen1, Qing Liu1, Junmei Xu1

  • 1Department of Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.

PubMed

Insights

Excessive mitochondrial fission contributes to sepsis-induced cardiomyopathy (SIC). Targeting the Nsun2/Ncor1 axis via epigenetic regulation offers a potential therapeutic strategy for septic cardiac injury.

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Biology
  • Molecular Medicine

Background:

  • Sepsis-induced cardiomyopathy (SIC) involves mitochondrial dysfunction and impaired heart contractility.
  • The precise molecular mechanisms driving SIC pathogenesis are not fully understood.

Purpose of the Study:

  • To investigate the role of mitochondrial dynamics in SIC.
  • To identify key molecular players and pathways involved in SIC.
  • To explore potential therapeutic targets for SIC.

Main Methods:

  • Utilized in vivo and in vitro models of SIC, including lipopolysaccharide (LPS) and cecal ligation and puncture (CLP) mouse models.
  • Employed pharmacological inhibition of mitochondrial fission (Mdivi-1) and lentiviral-mediated gene knockdown (Ncor1, Nsun2).
  • Performed bioinformatic analyses of public datasets and assessed molecular mechanisms including m5C methylation and mRNA stability.

Main Results:

  • Excessive mitochondrial fission was identified as a critical factor in SIC, promoting inflammation, oxidative stress, and cardiomyocyte apoptosis.
  • Pharmacological inhibition of mitochondrial fission attenuated SIC pathology.
  • Nuclear receptor corepressor 1 (Ncor1) was upregulated in SIC and its knockdown mitigated myocardial injury.
  • The RNA m5C methyltransferase Nsun2 was upregulated and enhanced Ncor1 mRNA stability via m5C methylation.
  • Nsun2 knockdown ameliorated cardiomyocyte injury, while Ncor1 knockdown reversed Nsun2 overexpression effects.

Conclusions:

  • A novel Nsun2/Ncor1 axis drives mitochondrial dysfunction in SIC through epigenetic regulation.
  • This axis represents a potential therapeutic target for mitigating septic cardiac injury.